FDA Oncology/X
Jun 30, 2025, 04:52
FDA Oncology Highlights CURE ID for Sharing Off-Label Treatment Experiences in Rare Cancer
FDA Oncology shared a post on X:
“Physicians – Your off-label treatment experiences – both successes and failures – could help others. CURE ID makes it easy to share rare cancer cases on a trusted platform – hosted by US FDA and NIH, NCATS.
Start now.”
More posts featuring FDA Oncology on OcnoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 08:02
Sep 8, 2025, 07:51
Sep 8, 2025, 07:43
Sep 8, 2025, 07:33
Sep 8, 2025, 07:27
Sep 8, 2025, 07:17
Sep 8, 2025, 07:07